These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22043004)

  • 1. Gipr is essential for adrenocortical steroidogenesis; however, corticosterone deficiency does not mediate the favorable metabolic phenotype of Gipr(-/-) mice.
    Bates HE; Campbell JE; Ussher JR; Baggio LL; Maida A; Seino Y; Drucker DJ
    Diabetes; 2012 Jan; 61(1):40-8. PubMed ID: 22043004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked cortisol production by intracrine ACTH in GIP-treated cultured adrenal cells in which the GIP receptor was exogenously introduced.
    Fujii H; Tamamori-Adachi M; Uchida K; Susa T; Nakakura T; Hagiwara H; Iizuka M; Okinaga H; Tanaka Y; Okazaki T
    PLoS One; 2014; 9(10):e110543. PubMed ID: 25334044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway.
    Mazzocchi G; Rebuffat P; Meneghelli V; Malendowicz LK; Tortorella C; Gottardo G; Nussdorfer GG
    Peptides; 1999; 20(5):589-94. PubMed ID: 10465510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.
    N'Diaye N; Tremblay J; Hamet P; De Herder WW; Lacroix A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2781-5. PubMed ID: 9709947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
    Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.
    Zhang Q; Delessa CT; Augustin R; Bakhti M; Colldén G; Drucker DJ; Feuchtinger A; Caceres CG; Grandl G; Harger A; Herzig S; Hofmann S; Holleman CL; Jastroch M; Keipert S; Kleinert M; Knerr PJ; Kulaj K; Legutko B; Lickert H; Liu X; Luippold G; Lutter D; Malogajski E; Medina MT; Mowery SA; Blutke A; Perez-Tilve D; Salinno C; Sehrer L; DiMarchi RD; Tschöp MH; Stemmer K; Finan B; Wolfrum C; Müller TD
    Cell Metab; 2021 Apr; 33(4):833-844.e5. PubMed ID: 33571454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological roles of the GIP receptor in murine brown adipose tissue.
    Beaudry JL; Kaur KD; Varin EM; Baggio LL; Cao X; Mulvihill EE; Bates HE; Campbell JE; Drucker DJ
    Mol Metab; 2019 Oct; 28():14-25. PubMed ID: 31451430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.
    Fu Y; Kaneko K; Lin HY; Mo Q; Xu Y; Suganami T; Ravn P; Fukuda M
    Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32603429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome.
    Antonini SR; Baldacchino V; Tremblay J; Hamet P; Lacroix A
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):29-36. PubMed ID: 16402925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
    Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
    Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
    J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
    Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
    J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?
    Swords FM; Aylwin S; Perry L; Arola J; Grossman AB; Monson JP; Clark AJ
    J Clin Endocrinol Metab; 2005 May; 90(5):3009-16. PubMed ID: 15705925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.
    Irwin N; Hunter K; Flatt PR
    Peptides; 2007 Nov; 28(11):2192-8. PubMed ID: 17884253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistin knockout mice exhibit impaired adipocyte glucose-dependent insulinotropic polypeptide receptor (GIPR) expression.
    Kim SJ; Nian C; McIntosh CH
    Diabetes; 2013 Feb; 62(2):471-7. PubMed ID: 23002036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF1 links GIPR signaling to the control of beta cell function and survival.
    Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
    Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice.
    Wang XS; Jiang YL; Lu L; Feng B; Ma X; Zhang K; Guan SY; Yang L; Fan QY; Zhu XC; Yang F; Qi JY; Yang LK; Li XB; Zhao MG; Jiang W; Tian Z; Liu SB
    Front Endocrinol (Lausanne); 2022; 13():887238. PubMed ID: 35712239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
    Miyawaki K; Yamada Y; Ban N; Ihara Y; Tsukiyama K; Zhou H; Fujimoto S; Oku A; Tsuda K; Toyokuni S; Hiai H; Mizunoya W; Fushiki T; Holst JJ; Makino M; Tashita A; Kobara Y; Tsubamoto Y; Jinnouchi T; Jomori T; Seino Y
    Nat Med; 2002 Jul; 8(7):738-42. PubMed ID: 12068290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.
    Gabe MBN; Skov-Jeppesen K; Gasbjerg LS; Schiellerup SP; Martinussen C; Gadgaard S; Boer GA; Oeke J; Torz LJ; Veedfald S; Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ; Hartmann B; Rosenkilde MM
    Pharmacol Res; 2022 Feb; 176():106058. PubMed ID: 34995796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.